Author: Hübner M, Kusamura S, Villeneuve L, Al-Niaimi A, Alyami M, Balonov K, Bell J, Bristow R, Guiral DC, Fagotti A, Falcão LFR, Glehen O, Lambert L, Mack L, Muenster T, Piso P, Pocard M, Rau B, Sgarbura O, Somashekhar SP, Wadhwa A, Altman A, Fawcett W, Veerapong J, Nelson G
Year: 2020
AGREE II score: Available
Developer organization: Enhanced Recovery After Surgery Society
Type of cancer: Not disease site specific
Patient population: Adult
Location: International
This is a clinical practice guideline for patients with peritoneal surface malignancies. Recommendations are provided on the use of cytoreductive surgery with or without the addition of hyperthermic intra-peritoneal chemotherapy, for the treatment of these patients. Part one of a two-part series, this guideline specifically discusses pre-operative and intra-operative management.
AGREE II - Quality of Reporting Assessment:
Scope and purpose: 47.2%
Applicability: 16.7%
Stakeholder involvement: 33.3%
Editorial independence: 41.7%
Rigour: 61.5%
Clarity presentation: 91.7%
